Driven by advances in electronic miniaturization, probe construction techniques and computing power, medical ultrasound is experiencing a trend toward smaller, lower cost systems with real-time volumetric imaging capabilities. These new attributes provide the opportunity to improve and expand the clinical utility of ultrasound to new applications. The combination of miniaturization and new attributes permits the expansion to previously underserved populations. Cardiovascular parameters for screening and monitoring, such as in a bedside or ambulatory setting, is one of these untapped areas that can benefit from quantitative, non-invasive measurements. Continuous and accurate measures of arterial parameters will provide additional information for earlier detection and more effective treatment of diseases, such as atherosclerosis and hypertension, while the clinical utility of any new measure will ultimately be determine by the reliability. Preliminary studies on in vitro and in vivo models have shown the potential of ultrasound hemodynamic measures in a laboratory setting. The proposal aims to develop and validate quantitative hemodynamic measures for new cardiovascular applications on next generation volumetric ultrasound systems. The technical development specifically focuses on reliable measurement algorithms for (1) quantitative arterial area and volumetric flow rate, (2) arterial compliance, and (3) continuous blood pressure. The approach utilizes volumetric ultrasound to provide structural information allowing typical qualitative ultrasound measures to be converted into quantitative measures. By combining volumetric ultrasound with automatic methods to locate the vessel and continuously process the data, the reliability and ease of use can be improved to the point where a sonographer is not required. A simplified 3-D architecture developed from existing hardware will be modified for these feasibility studies, and the ultrasound-based quantitative hemodynamic measures will be validated and the measurement variation quantified using invasive flow and pressure sensors under a variety of physiological conditions during acute and chronic studies in anesthetized and conscious canine models.

Public Health Relevance

The goal is to detect cardiovascular disease earlier in the disease process, before any obvious symptoms appear and during which treatment is far easier and cost effective. This will be achieved through the development of new ultrasound measurement techniques, validated through in vivo animal studies, for key arterial parameters to supply information about vascular health including the measurement of arterial stiffness and continuous monitoring of blood flow and pressure within the artery. It is the intent to make such parameters easier to mea- sure using noninvasive automated methods based on the use of highly miniaturized low-cost ultrasound imag- ers, making these measurements available to a broader group of clinical users, including primary care physi- cians.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL094487-02
Application #
7894745
Study Section
Biomedical Imaging Technology Study Section (BMIT)
Program Officer
Ulisney, Karen
Project Start
2009-07-15
Project End
2013-03-31
Budget Start
2010-07-01
Budget End
2013-03-31
Support Year
2
Fiscal Year
2010
Total Cost
$815,459
Indirect Cost
Name
General Electric Global Research Center
Department
Type
DUNS #
086188401
City
Niskayuna
State
NY
Country
United States
Zip Code
12309
Dentinger, Aaron M; Hoctor, Ralph T (2010) Non-invasive hemodynamic state monitoring using ultrasound. Conf Proc IEEE Eng Med Biol Soc 2010:5306-9